(1)
EQS Group-Ad-hoc: Medacta Group SA / Key word(s): Regulatory Approval
Medacta Announces the Registration of the Knee, Shoulder and Spine Applications of its NextAR Augmented Reality Surgical Platform in Europe, and the Shoulder Application to the American Market
27-May-2021 / 19:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Press release
Medacta Announces the Registration of the Knee, Shoulder and Spine Applications of its NextAR Augmented Reality Surgical Platform in Europe, and the Addition of the Shoulder Application to the American Market
- Medacta s Knee, Shoulder and Spine Applications received CE-marking, and Medacta s Shoulder Application also obtained FDA-clearance.
May 12, 2021
Frances Faye Hromada (nee Bushby) passed away from the complications of dementia in Drumheller Long Term Care Unit on May 12, 2021 at the age of 82 years.
As a result of COVID-19 restrictions and government recommendations, there will be no formal public memorial.
She is lovingly remembered and loved by her two sons
Kelly and Darren (Sylvia). Grandchildren: Shaun (Wendy),
Jason, Danielle (Jed), Candice (Jacob), and Kari. Great grandchildren: Paxton, Phoenix, Autumn and Harlie. She is also survived by her sister Diane Borgstrom of Calgary.
She was predeceased by her mother, Margaret Bushby, and stepfather James Bushby, her sister Lynn Gardener as well as her 3rd son Derek Shawn.
Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in total knee and total hip replacement surgery.